Kelsey Armitage
YOU?
Author Swipe
View article: Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record in the UK (ALABAMA): an open-label, multicentre, randomised controlled trial
Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record in the UK (ALABAMA): an open-label, multicentre, randomised controlled trial Open
View article: Patients’ acceptance of a penicillin allergy de-labelling programme in primary care: a qualitative study
Patients’ acceptance of a penicillin allergy de-labelling programme in primary care: a qualitative study Open
Background About 6% of the UK general practice population has a record of a penicillin allergy but fewer than 10% of these people are likely to be truly allergic. Consequently, a significant portion of the population is denied first-line a…
View article: Healthcare professionals' experiences of de-labelling erroneous penicillin allergy records in general practice: a qualitative study
Healthcare professionals' experiences of de-labelling erroneous penicillin allergy records in general practice: a qualitative study Open
Background Penicillin allergy (PenA) prevalence is approximately 6%, but fewer than 10% of these people are expected to be truly allergic. Consequently, a significant proportion of the population are prescribed alternative antibiotics with…
View article: Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessment
Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessment Open